Increased transfusion-free survival following auxiliary pig liver xenotransplantation

Xenotransplantation

Volumn 21, Issue 5, 2014, Pages 454-464

  Yeh, Heidi ^a   Machaidze, Zurab ^a   Wamala, Isaac ^a   Fraser, James W ^a   Navarro Alvarez, Nalu ^a   Kim, Karen ^a   Schuetz, Christian ^a   Shi, Shuai ^a   Zhu, Alexander ^a   Hertl, Martin ^a   Elias, Nahel ^a   Farkash, Evan A ^a   Vagefi, Parsia A ^a   Varma, Manish ^a   Smith, Rex Neal ^a   Robson, Simon C ^b   Van Cott, Elizabeth M ^a   Sachs, David H ^a   Markmann, James F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

coagulopathy; liver xenotransplantation; thrombocytopenia

Indexed keywords

FIBRINOGEN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; AUXILIARY LIVER XENOTRANSPLANTATION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; FIBRINOGEN BLOOD LEVEL; FLOW CYTOMETRY; GALACTOSYLTRANSFERASE GENE KNOCKOUT PIG; GRAFT FAILURE; GRAFT SURVIVAL; HEMATOCRIT; INFECTION RISK; INFECTIOUS COMPLICATION; LIVER TRANSPLANTATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; ANIMAL; BABOON; BLOOD; BLOOD TRANSFUSION; EVALUATION STUDY; GENETICS; GRAFT REJECTION; METABOLISM; MORTALITY; PIG; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROCEDURES; TRANSGENIC ANIMAL; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; GRAFT REJECTION; GRAFT SURVIVAL; LIVER TRANSPLANTATION; PAPIO; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; SWINE; THROMBOCYTOPENIA; TRANSPLANTATION, HETEROLOGOUS;

EID: 84925633813     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/xen.12111     Document Type: Article

References (36)

1. Kim WR, Brown RS Jr, Terrault NA, El-Serag H,. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002; 36: 227-242.
2. http://optn.transplant.hrsa.org
3. Ekser B, Rigotti P, Gridell B, Cooper DKC,. Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol 2009; 21: 87-92.
4. Cooper DKC, Ezzelarab M, Hara H, Dayares D,. Recent advances in pig-to-human organ and cell transplantation. Expert Opin Biol Ther 2008; 8: 1-4.
5. Kim K, Schuetz C, Elias N, et al. Up to 9-day survival and control of thrombocytopenia following alpha 1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons. Xenotransplantation 2012; 19: 236-264.
6. Ekser B, Long C, Echeverri GJ, et al. Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transpl 2010; 10: 273-285.
7. Schulte am Esch J, Cruz MA, Siegel JB, Anrather J, Robson SC,. Activation of human platelets by the membrane-expressed A1 domain of von Willebrand Factor. Blood 1997; 90: 4425-4437.
8. Schulte am Exch J II, Robson SC, Knoefel WT, Hosch SB, Rogiers x,. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors. Xenotransplantation 2005; 12: 30-37.
9. Lin CC, Chen D, McVey JH, Cooper DKC, Dorling A,. Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells. Transplantation 2008; 86: 702-709.
10. Ezzelerab M, Ekser B, Gridelli B, et al. Thrombocytopenia after pig-to-baboon liver xenotransplantation: where do platelets go? Xenotransplantation 2011; 18: 320-327.
11. Burlak C, Paris LL, Chihara RK, et al. The fate of human platelets perfused through the pig liver: implications for xenotransplantation. Xenotransplantation 2010; 17: 350-361.
12. Paris LL, Chihara RK, Reyes LM, et al. ASGR1 expressed by porcine enriched liver sinusoidal endothelial cells mediates human platelet phagocytosis in vitro. Xenotransplantation 2011; 18: 245-251.
13. Paris LL, Chihara RK, Sidner RA, Tector AJ, Burlak C,. Differences in human and porcine platelet oligosaccharides may influence phagocytosis by liver sinusoidal cells in vitro. Xenotransplantation 2012; 19: 31-39.
14. Chihara RK, Paris LL, Reyes LM, et al. Primary porcine kupffer cell phagocytosis of human platelets involves the CD18 receptor. Transplantation 2011; 92: 739-744.
15. Peng Q, Yeh H, Wei L, et al. Mechanisms of xenogeneic baboon platelet aggregation and phagocytosis by porcine liver sinusoidal endothelial cells. PLoS ONE 2012; 7: e47273.
16. Ekser B, Klein E, He J, et al. Genetically engineered pig-to-baboon liver xenotransplantation: histopathology of xenografts and native organs. PLoS ONE 2012; 7: e29720.
17. Ramirez P, Chavez R, Majado M, et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 2000; 70: 989-998.
18. Ekser B, Gridelli B, Veroux M, Cooper DKC,. Clinical pig liver xenotransplantation: how far do we have to go? Xenotransplantation 2011; 18: 158-167.
19. Haga J, Shimazu M, Wakabayashi G, et al. Liver regeneration in donors and adult recipients after living donor liver transplantation. Liver Transpl 2008; 14: 1718-1724.
20. Watanabe FK, Mullon CJP, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. Ann Surg 1997; 225: 484-494.
21. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha 1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29.
22. Tseng YL, Kuwaki K, Dor JF, et al. Alpha 1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005; 80: 1493.
23. Shimizu A, Hisashi Y, Kuwaki K, et al. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha-1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol 2008; 172: 1471-1481.
24. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of renal xenograft survival in baboons through the use of alpha 1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2004; 11: 32-34.
25. Shimizu A, Yamada K, Yamamoto S, et al. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol 2005; 15: 2732-2745.
26. O'Leary JG, Klintmalm GB,. Impact of donor-specific antibodies on results of liver transplantation. Curr Opin Organ Transplant. 2013; 18: 279-284.
27. Bogetti D, Jarzembowski TM, Sankary HN, et al. Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy. Transpl Proc 2005; 37: 404-406.
28. Bogetti D, Sankary HN, Jarzembowski TM, et al. Thymoglobulin induction protects liver allograft from ischemia/reperfusion injury. Clin Transplant 2005; 19: 507-11.
29. Mehrabi A, Mood ZA, Sadeghi M, et al. Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. Nephrol Dial Transplant 2007; 22: 54-60.
30. Miwa Y, Yamamoto K, Onishi A, et al. Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation. Xenotransplantation 2010; 17: 26-37.
31. Seigel J, Grey S, Lesnikoski B, et al. Xenogeneic endothelial cells activate human prothrombin 1,2. Transplantation 1997; 64: 888-896.
32. Roussel JC, Moran CJ, Salvaris EJ, et al. Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am J Transplant 2008; 8: 1101-1112.
33. Girelli D, Russo C, Ferraresi P, et al. Polymorphisms in the Factor VII gene and the risk myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343: 774-780.
34. Chen Y, Qiao J, Tan W, et al. Characterization of porcine factor VII, X and comparison with human factor VII, X. Blood Cells Mol Dis 2009; 43: 111-118.
35. Yau JW, Stafford AR, Liao P, et al. Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. Blood 2011; 118: 6667-6674.
36. Renne T, Schmaier AH, Nickel KF, et al. In vivo roles of Factor XII. Blood 2012; 120: 4296-4303.